Literature DB >> 25387900

Refeeding encephalopathy in a patient with severe hypophosphataemia and hyperammonaemia.

S Becker1, G Dam1, C L Hvas1.   

Abstract

The refeeding syndrome is a potentially fatal condition that affects multiple organ systems. It is the consequence of fluid and electrolyte shifts that may occur in a malnourished patient following the introduction of nutrition therapy. The most prominent characteristic is hypophosphataemia. Although hyperammonaemia is usually seen in decompensated liver cirrhosis or acute liver failure, it may occur in other settings. We report a clinical case of prolonged and severe encephalopathy accompanied by hypophosphataemia and hyperammonaemia in a 59-year-old woman with no preexisting liver disease, urea cycle defects or portosystemic shunting. We suggest that these biochemical abnormalities were caused by uncontrolled refeeding and that the clinical picture was consistent with refeeding encephalopathy.

Entities:  

Mesh:

Year:  2014        PMID: 25387900     DOI: 10.1038/ejcn.2014.244

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  10 in total

Review 1.  Refeeding syndrome: a clinical review.

Authors:  Clare Ormerod; Kirstine Farrer; Lindsay Harper; Simon Lal
Journal:  Br J Hosp Med (Lond)       Date:  2010-12       Impact factor: 0.825

2.  Centropontine myelinolysis related to refeeding syndrome in an adolescent suffering from anorexia nervosa.

Authors:  Sandrine Leroy; Ariel Gout; Beatrice Husson; Renault de Tournemire; Marc Tardieu
Journal:  Neuropediatrics       Date:  2012-04-02       Impact factor: 1.947

3.  Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver.

Authors:  Hendrik Vilstrup; Piero Amodio; Jasmohan Bajaj; Juan Cordoba; Peter Ferenci; Kevin D Mullen; Karin Weissenborn; Philip Wong
Journal:  Hepatology       Date:  2014-07-08       Impact factor: 17.425

4.  Control of urea synthesis and ammonia utilization in protein deprivation and refeeding.

Authors:  V Felipo; M D Miñana; S Grisolía
Journal:  Arch Biochem Biophys       Date:  1991-03       Impact factor: 4.013

Review 5.  Clinical and biochemical aspects of primary and secondary hyperammonemic disorders.

Authors:  Johannes Häberle
Journal:  Arch Biochem Biophys       Date:  2013-04-27       Impact factor: 4.013

6.  A possible hypophosphatemia-induced, life-threatening encephalopathy in diabetic ketoacidosis: a case report.

Authors:  Bruno Mégarbane; Gilles Guerrier; Anne Blancher; Taly Meas; Pierre-Jean Guillausseau; Frederic J Baud
Journal:  Am J Med Sci       Date:  2007-06       Impact factor: 2.378

7.  Hyperammonemic encephalopathy due to essential amino acid hyperalimentation.

Authors:  R E Grazer; J M Sutton; S Friedstrom; F D McBarron
Journal:  Arch Intern Med       Date:  1984-11

8.  Hyperammonemia in Marasmic children.

Authors:  M R Morsy; H Madina; S A Sharaf; A T Soliman; M M Elzalabany; M A Ramadan
Journal:  J Trop Pediatr       Date:  1994-04       Impact factor: 1.165

9.  Hypophosphatemic encephalopathy in a CAPD patient.

Authors:  Mohammad R Ardalan; Leili Pourafkari; R Shane Tubbs; Mohammadali M Shoja
Journal:  Am J Med Sci       Date:  2008-06       Impact factor: 2.378

10.  Hyperammonemic encephalopathy caused by carnitine deficiency.

Authors:  Berkeley N Limketkai; Stephen D Zucker
Journal:  J Gen Intern Med       Date:  2007-12-13       Impact factor: 5.128

  10 in total
  6 in total

1.  [Quality management in weight restitution in Anorexia nervosa--pathophysiology, evidence-based practice and prevention of the refeeding syndrome].

Authors:  Michael Mayr; Hartmut Imgart; Katrin Skala; Andreas Karwautz
Journal:  Neuropsychiatr       Date:  2015-11-23

2.  Refeeding encephalopathy revisited: Reply to Tasci et al.

Authors:  C L Hvas; S Becker; G Dam
Journal:  Eur J Clin Nutr       Date:  2015-03-18       Impact factor: 4.016

3.  Acid-base disturbances may complicate the diagnosis of refeeding syndrome.

Authors:  I Tasci; M F Bulucu; K Saglam
Journal:  Eur J Clin Nutr       Date:  2015-03-11       Impact factor: 4.016

4.  Drug-specific hypophosphatemia and hypersensitivity reactions following different intravenous iron infusions.

Authors:  Palle Bager; Christian L Hvas; Jens F Dahlerup
Journal:  Br J Clin Pharmacol       Date:  2017-01-18       Impact factor: 4.335

5.  Hyperammonaemic encephalopathy following an uncomplicated surgery.

Authors:  Stuart McIntosh; Karima Medjoub; Kevin Deans; Sara Sexton
Journal:  BMJ Case Rep       Date:  2017-08-16

6.  Treatable Leukoencephalopathy in a Patient with Hypophosphatemia.

Authors:  Masahiro Okazaki; Makito Hirano; Tomoki Iwatsu; Masaki Yamana; Hidekazu Suzuki; Takao Satou; Susumu Kusunoki
Journal:  Case Rep Neurol       Date:  2017-01-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.